Use of cb1 cannabinoid receptor as a marker of chromophobe cell renal carcinoma (crcch) and renal oncocytoma (or) (Machine-translation by Google Translate, not legally binding)

摘要

Use of the cb1 cannabinoid receptor as a marker of chromophobe cell renal carcinoma (crcch) and renal oncocytoma (or). The type 1 cannabinoid receptor (cb1) can be used as a marker for chromophobe cell renal carcinoma (crcch) and renal oncocytoma (or). The invention provides an in vitro method for diagnosing whether a subject suffers from a neoplasia originating in intercalary cells of the distal nephron, which comprises detecting, in a sample of said neoplasm of said subject, the presence of the type 1 cannabinoid receptor (cb1)., wherein the detection of the presence of cb1 in said sample is indicative that said subject suffers from a renal neoplasm originating in intercalary cells of the distal nephron, for example, crcch or or. Of application in medicine, in anatomopathological diagnosis. (Machine-translation by Google Translate, not legally binding)